let these two companies get together to overwhelm this industry and put generic to rest until 2010, These idiots portraying themselves as having knowledge about patents are more lies by the Shorts and probably lunesta, and ambian! There will be no patent ending on this stock until 2020. If an otc wants to try to advance their own cause, they will be bankrupt by our product. WE HAVE A 50 BILLION DOLLAR PRODUCT OVER THE NEXT TEN YEARS AND ANOTHER 50 BILLION OTC! DON't let the worms cut into our rewards..imo dp
Right, patenting HGB is bulletproof. Jazz couldn't afford to even go to court if a competitor submitted a hgb product for narcolepsey with a slightly different dose. 2 weeks up now it's 2 weeks down. Put buyers and shorts taken out now it's time for all the new shareholders and call buyers to be taken out. $8.50 or lower this week.